Ann: Change in CEO Remuneration and Non-Executive Directors' Fees, page-17

First 17 Last

Share
Profile

Follow
gogav

102 Posts.

7

29/11/19

16:27

Post #: 41714740
Share

Originally posted by SteveSage: ↑

Not sure it's true that the market does not get it wrong

Along with a range of other issues on VTG (not big on the radar of analysts, illiquid stock or more accurately trading volumes too low hence small turnover moves the price), what the market cannot understand is without the 12-13m in remuneration, what the pnl will looks like. Mgmt have only indicated they plan to replace this with higher hardware sales, but no indication whether this will fully replace the lost remuneration. Add to that they did not flag how they were doing at the AGM so a lot of unknowns.

Arguably, if there was a significant decline they should have flagged it to the market (not sure if just highlighting loss of remuneration counts as a profit warning, but who knows).

On balance you'd prefer this remuneration over hardware sales because now you have to sell product to earn revenues each year, but at these prices, the market has priced in a lot of downside already

FY 2019 NPBT 34m, NPAT 24m, EPS 15c
if you assume that the full 13m in remuneration drops into PBT
Adj FY2019 NPBT 21m, NPAT15m, EPS 9c

Not ideal, but at current price, not end of the world (IMO).

Expand

Oops! Now this one is failing on compliance issues. Good thing remuneration is cut before shareholders have their say. Very disappointed as we close in on 5 year lows.

VTG Price at posting: $1.07 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome